table of content
1 Study Coverage
1.1 Polio (Poliomyelitis) Vaccines Product Introduction
1.2 Global Polio (Poliomyelitis) Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Polio (Poliomyelitis) Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Polio (Poliomyelitis) Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Polio (Poliomyelitis) Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Polio (Poliomyelitis) Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Polio (Poliomyelitis) Vaccines Sales in Volume for the Year 2017-2028
1.4 Polio (Poliomyelitis) Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Polio (Poliomyelitis) Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Polio (Poliomyelitis) Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Polio (Poliomyelitis) Vaccines Market Dynamics
1.5.1 Polio (Poliomyelitis) Vaccines Industry Trends
1.5.2 Polio (Poliomyelitis) Vaccines Market Drivers
1.5.3 Polio (Poliomyelitis) Vaccines Market Challenges
1.5.4 Polio (Poliomyelitis) Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Polio (Poliomyelitis) Vaccines Market Segment by Type
2.1.1 Inactivated Polio Vaccine (IPV)
2.1.2 Oral Polio Vaccine (OPV)
2.2 Global Polio (Poliomyelitis) Vaccines Market Size by Type
2.2.1 Global Polio (Poliomyelitis) Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Polio (Poliomyelitis) Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Polio (Poliomyelitis) Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Polio (Poliomyelitis) Vaccines Market Size by Type
2.3.1 United States Polio (Poliomyelitis) Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Polio (Poliomyelitis) Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Polio (Poliomyelitis) Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Polio (Poliomyelitis) Vaccines Market Segment by Application
3.1.1 Research & Academic Laboratories
3.1.2 Pharmaceutical & Biotechnology Companies
3.1.3 Others
3.2 Global Polio (Poliomyelitis) Vaccines Market Size by Application
3.2.1 Global Polio (Poliomyelitis) Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Polio (Poliomyelitis) Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Polio (Poliomyelitis) Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Polio (Poliomyelitis) Vaccines Market Size by Application
3.3.1 United States Polio (Poliomyelitis) Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Polio (Poliomyelitis) Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Polio (Poliomyelitis) Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Polio (Poliomyelitis) Vaccines Competitor Landscape by Company
4.1 Global Polio (Poliomyelitis) Vaccines Market Size by Company
4.1.1 Top Global Polio (Poliomyelitis) Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Polio (Poliomyelitis) Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Polio (Poliomyelitis) Vaccines Price by Manufacturer (2017-2022)
4.2 Global Polio (Poliomyelitis) Vaccines Concentration Ratio (CR)
4.2.1 Polio (Poliomyelitis) Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Polio (Poliomyelitis) Vaccines in 2021
4.2.3 Global Polio (Poliomyelitis) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Polio (Poliomyelitis) Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Polio (Poliomyelitis) Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Polio (Poliomyelitis) Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Polio (Poliomyelitis) Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Polio (Poliomyelitis) Vaccines Market Size by Company
4.5.1 Top Polio (Poliomyelitis) Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Polio (Poliomyelitis) Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Polio (Poliomyelitis) Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Polio (Poliomyelitis) Vaccines Market Size by Region
5.1 Global Polio (Poliomyelitis) Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Polio (Poliomyelitis) Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Polio (Poliomyelitis) Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Polio (Poliomyelitis) Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Polio (Poliomyelitis) Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Polio (Poliomyelitis) Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Polio (Poliomyelitis) Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Polio (Poliomyelitis) Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Polio (Poliomyelitis) Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Polio (Poliomyelitis) Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Polio (Poliomyelitis) Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Polio (Poliomyelitis) Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Polio (Poliomyelitis) Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Polio (Poliomyelitis) Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Polio (Poliomyelitis) Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Corporation Information
7.1.2 Sanofi Description and Business Overview
7.1.3 Sanofi Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Sanofi Polio (Poliomyelitis) Vaccines Products Offered
7.1.5 Sanofi Recent Development
7.2 GSK
7.2.1 GSK Corporation Information
7.2.2 GSK Description and Business Overview
7.2.3 GSK Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 GSK Polio (Poliomyelitis) Vaccines Products Offered
7.2.5 GSK Recent Development
7.3 Bibcol
7.3.1 Bibcol Corporation Information
7.3.2 Bibcol Description and Business Overview
7.3.3 Bibcol Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bibcol Polio (Poliomyelitis) Vaccines Products Offered
7.3.5 Bibcol Recent Development
7.4 Serum Institute
7.4.1 Serum Institute Corporation Information
7.4.2 Serum Institute Description and Business Overview
7.4.3 Serum Institute Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Serum Institute Polio (Poliomyelitis) Vaccines Products Offered
7.4.5 Serum Institute Recent Development
7.5 Tiantan Biological
7.5.1 Tiantan Biological Corporation Information
7.5.2 Tiantan Biological Description and Business Overview
7.5.3 Tiantan Biological Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Tiantan Biological Polio (Poliomyelitis) Vaccines Products Offered
7.5.5 Tiantan Biological Recent Development
7.6 IMBCA
7.6.1 IMBCA Corporation Information
7.6.2 IMBCA Description and Business Overview
7.6.3 IMBCA Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 IMBCA Polio (Poliomyelitis) Vaccines Products Offered
7.6.5 IMBCA Recent Development
7.7 Panacea Biotec Ltd
7.7.1 Panacea Biotec Ltd Corporation Information
7.7.2 Panacea Biotec Ltd Description and Business Overview
7.7.3 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Products Offered
7.7.5 Panacea Biotec Ltd Recent Development
7.8 Bio-Med
7.8.1 Bio-Med Corporation Information
7.8.2 Bio-Med Description and Business Overview
7.8.3 Bio-Med Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Bio-Med Polio (Poliomyelitis) Vaccines Products Offered
7.8.5 Bio-Med Recent Development
7.9 Halfkin Bio-Pharmaceuticals
7.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
7.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
7.9.3 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Products Offered
7.9.5 Halfkin Bio-Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Polio (Poliomyelitis) Vaccines Industry Chain Analysis
8.2 Polio (Poliomyelitis) Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Polio (Poliomyelitis) Vaccines Distributors
8.3 Polio (Poliomyelitis) Vaccines Production Mode & Process
8.4 Polio (Poliomyelitis) Vaccines Sales and Marketing
8.4.1 Polio (Poliomyelitis) Vaccines Sales Channels
8.4.2 Polio (Poliomyelitis) Vaccines Distributors
8.5 Polio (Poliomyelitis) Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
